Please enable JavaScript to continue using this application.

Compare $PYXS vs $TLSI | Chartloom

Compare

$PYXS vs $TLSI

Pyxis Oncology Inc · TriSalus Life Sciences Inc

PYXS

Pyxis Oncology Inc

TLSI

TriSalus Life Sciences Inc

Compare $PYXS vs $TLSI

Comparing Pyxis Oncology Inc and TriSalus Life Sciences Inc

PYXSPyxis Oncology Inc

TLSITriSalus Life Sciences Inc

PYXSPyxis Oncology Inc

Market cap

$168M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-14.2%

YTD performance

76.5%

52W performance

-30.2%

FCF yield

-40.3%

TLSITriSalus Life Sciences Inc

Market cap

$249M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.61x

Rev growth (TTM)

25.2%

YTD performance

-33.4%

52W performance

-16.3%

FCF yield

-9.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PYXS

TLSI

Detailed metrics comparison

PYXS

Pyxis Oncology Inc

TLSI

TriSalus Life Sciences Inc

Market Cap

PYXS$168M

TLSI$249M

Enterprise Value

PYXS$150M

TLSI$236M

Price

PYXS$2.03

TLSI$4.06

P/E Ratio

PYXSN/A

TLSIN/A

P/S Ratio

PYXS15.26x

TLSI5.53x

EV/Sales

PYXS13.55x

TLSI5.24x

EV/EBITDA

PYXS0.00x

TLSI0.00x

P/B Ratio

PYXS15.60x

TLSI40.61x

P/FCF Ratio

PYXSN/A

TLSIN/A

EV/FCF

PYXS-2.20x

TLSI-10.14x

PEG Ratio

PYXSN/A

TLSIN/A

Forward P/E (NTM)

PYXSN/A

TLSIN/A

Forward P/S (NTM)

PYXSN/A

TLSI3.61x

Revenue (TTM)

PYXS$11M

TLSI$45M

Revenue Growth (YoY)

PYXS-14.2%

TLSI25.2%

Forward Rev Growth

PYXS14187.3%

TLSI40.1%

Gross Margin (TTM)

PYXS78.4%

TLSI85.8%

Operating Margin (TTM)

PYXS0.0%

TLSI0.0%

EBITDA Margin (TTM)

PYXS-580.0%

TLSI-66.4%

Net Margin (TTM)

PYXS-593.0%

TLSI-130.2%

FCF Margin (TTM)

PYXS-615.3%

TLSI-51.6%

Net Income (TTM)

PYXS$-65M

TLSI$-59M

FCF (TTM)

PYXS$-68M

TLSI$-23M

EPS (TTM)

PYXS-$1.03

TLSI-$1.01

ROE (TTM)

PYXS-10177.0%

TLSI-7902.0%

ROA (TTM)

PYXS-6981.0%

TLSI-5499.0%

ROIC (TTM)

PYXS-10171.0%

TLSI-1789.0%

Cash

PYXS$19M

TLSI$46M

Debt

PYXS$0

TLSI$33M

Net Cash/Debt

PYXS$19M

TLSI$13M

Current Ratio (TTM)

PYXS1.34x

TLSI5.35x

Quick Ratio (TTM)

PYXS1.25x

TLSI4.72x

Debt/Equity (TTM)

PYXS0.00x

TLSI5.05x

Debt/Assets (TTM)

PYXS0.0%

TLSI0.0%

Interest Coverage (TTM)

PYXSN/A

TLSIN/A

Net Debt/EBITDA (TTM)

PYXS0.00x

TLSI0.00x

Beta

PYXS1.37

TLSI0.46

52W Performance

PYXS-30.2%

TLSI-16.3%

YTD Performance

PYXS76.5%

TLSI-33.4%

% from 52W High

PYXS-63.4%

TLSI-48.9%

% from 52W Low

PYXS97.1%

TLSI84.5%

Asset Turnover (TTM)

PYXS0.00x

TLSI0.88x

FCF Yield (TTM)

PYXS-40.3%

TLSI-9.3%

Earnings Yield (TTM)

PYXS-38.9%

TLSI-23.5%

Dividend Yield (TTM)

PYXSN/A

TLSIN/A

Rule of 40

PYXS-629.5

TLSI-26.4

EV/GP/RG

PYXS0.00

TLSI0.11

Ticker research

View PYXS research View TLSI research

Metric	PYXS Pyxis Oncology Inc	TLSI TriSalus Life Sciences Inc
Market & Valuation
Market Cap	$168M	$249M
Enterprise Value	$150M	$236M
Price	$2.03	$4.06
P/E Ratio	N/A	N/A
P/S Ratio	15.26x	5.53x
EV/Sales	13.55x	5.24x
EV/EBITDA	0.00x	0.00x
P/B Ratio	15.60x	40.61x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.20x	-10.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.61x
Revenue & Growth
Revenue (TTM)	$11M	$45M
Revenue Growth (YoY)	-14.2%	25.2%
Forward Rev Growth	14187.3%	40.1%
Profitability
Gross Margin (TTM)	78.4%	85.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-580.0%	-66.4%
Net Margin (TTM)	-593.0%	-130.2%
FCF Margin (TTM)	-615.3%	-51.6%
Net Income (TTM)	$-65M	$-59M
FCF (TTM)	$-68M	$-23M
EPS (TTM)	-$1.03	-$1.01
ROE (TTM)	-10177.0%	-7902.0%
ROA (TTM)	-6981.0%	-5499.0%
ROIC (TTM)	-10171.0%	-1789.0%
Financial Health
Cash	$19M	$46M
Debt	$0	$33M
Net Cash/Debt	$19M	$13M
Current Ratio (TTM)	1.34x	5.35x
Quick Ratio (TTM)	1.25x	4.72x
Debt/Equity (TTM)	0.00x	5.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	0.46
52W Performance	-30.2%	-16.3%
YTD Performance	76.5%	-33.4%
% from 52W High	-63.4%	-48.9%
% from 52W Low	97.1%	84.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.88x
FCF Yield (TTM)	-40.3%	-9.3%
Earnings Yield (TTM)	-38.9%	-23.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-629.5	-26.4
EV/GP/RG	0.00	0.11
Ticker research	View PYXS research	View TLSI research

Valuation

P/S Ratio

TLSI

5.53x

PYXS

15.26x

EV/FCF

TLSI

-10.14x

PYXS

-2.20x

Growth & revenue

Revenue Growth TTM

TLSI

25.2%

PYXS

-14.2%

Forward Revenue Growth

PYXS

14187.3%

TLSI

40.1%

Profitability & performance

Gross Margin

TLSI

85.8%

PYXS

78.4%

ROE

TLSI

-7902.0%

PYXS

-10177.0%

FCF Yield %

TLSI

-9.3%

PYXS

-40.3%

52-Week Performance

TLSI

-16.3%

PYXS

-30.2%

Detailed metrics comparison

PYXS

Pyxis Oncology Inc

TLSI

TriSalus Life Sciences Inc

Market Cap

PYXS$168M

TLSI$249M

Enterprise Value

PYXS$150M

TLSI$236M

Price

PYXS$2.03

TLSI$4.06

P/E Ratio

PYXSN/A

TLSIN/A

P/S Ratio

PYXS15.26x

TLSI5.53x

EV/Sales

PYXS13.55x

TLSI5.24x

EV/EBITDA

PYXS0.00x

TLSI0.00x

P/B Ratio

PYXS15.60x

TLSI40.61x

P/FCF Ratio

PYXSN/A

TLSIN/A

EV/FCF

PYXS-2.20x

TLSI-10.14x

PEG Ratio

PYXSN/A

TLSIN/A

Forward P/E (NTM)

PYXSN/A

TLSIN/A

Forward P/S (NTM)

PYXSN/A

TLSI3.61x

Revenue (TTM)

PYXS$11M

TLSI$45M

Revenue Growth (YoY)

PYXS-14.2%

TLSI25.2%

Forward Rev Growth

PYXS14187.3%

TLSI40.1%

Gross Margin (TTM)

PYXS78.4%

TLSI85.8%

Operating Margin (TTM)

PYXS0.0%

TLSI0.0%

EBITDA Margin (TTM)

PYXS-580.0%

TLSI-66.4%

Net Margin (TTM)

PYXS-593.0%

TLSI-130.2%

FCF Margin (TTM)

PYXS-615.3%

TLSI-51.6%

Net Income (TTM)

PYXS$-65M

TLSI$-59M

FCF (TTM)

PYXS$-68M

TLSI$-23M

EPS (TTM)

PYXS-$1.03

TLSI-$1.01

ROE (TTM)

PYXS-10177.0%

TLSI-7902.0%

ROA (TTM)

PYXS-6981.0%

TLSI-5499.0%

ROIC (TTM)

PYXS-10171.0%

TLSI-1789.0%

Cash

PYXS$19M

TLSI$46M

Debt

PYXS$0

TLSI$33M

Net Cash/Debt

PYXS$19M

TLSI$13M

Current Ratio (TTM)

PYXS1.34x

TLSI5.35x

Quick Ratio (TTM)

PYXS1.25x

TLSI4.72x

Debt/Equity (TTM)

PYXS0.00x

TLSI5.05x

Debt/Assets (TTM)

PYXS0.0%

TLSI0.0%

Interest Coverage (TTM)

PYXSN/A

TLSIN/A

Net Debt/EBITDA (TTM)

PYXS0.00x

TLSI0.00x

Beta

PYXS1.37

TLSI0.46

52W Performance

PYXS-30.2%

TLSI-16.3%

YTD Performance

PYXS76.5%

TLSI-33.4%

% from 52W High

PYXS-63.4%

TLSI-48.9%

% from 52W Low

PYXS97.1%

TLSI84.5%

Asset Turnover (TTM)

PYXS0.00x

TLSI0.88x

FCF Yield (TTM)

PYXS-40.3%

TLSI-9.3%

Earnings Yield (TTM)

PYXS-38.9%

TLSI-23.5%

Dividend Yield (TTM)

PYXSN/A

TLSIN/A

Rule of 40

PYXS-629.5

TLSI-26.4

EV/GP/RG

PYXS0.00

TLSI0.11

Ticker research

View PYXS research View TLSI research

Metric	PYXS Pyxis Oncology Inc	TLSI TriSalus Life Sciences Inc
Market & Valuation
Market Cap	$168M	$249M
Enterprise Value	$150M	$236M
Price	$2.03	$4.06
P/E Ratio	N/A	N/A
P/S Ratio	15.26x	5.53x
EV/Sales	13.55x	5.24x
EV/EBITDA	0.00x	0.00x
P/B Ratio	15.60x	40.61x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.20x	-10.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.61x
Revenue & Growth
Revenue (TTM)	$11M	$45M
Revenue Growth (YoY)	-14.2%	25.2%
Forward Rev Growth	14187.3%	40.1%
Profitability
Gross Margin (TTM)	78.4%	85.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-580.0%	-66.4%
Net Margin (TTM)	-593.0%	-130.2%
FCF Margin (TTM)	-615.3%	-51.6%
Net Income (TTM)	$-65M	$-59M
FCF (TTM)	$-68M	$-23M
EPS (TTM)	-$1.03	-$1.01
ROE (TTM)	-10177.0%	-7902.0%
ROA (TTM)	-6981.0%	-5499.0%
ROIC (TTM)	-10171.0%	-1789.0%
Financial Health
Cash	$19M	$46M
Debt	$0	$33M
Net Cash/Debt	$19M	$13M
Current Ratio (TTM)	1.34x	5.35x
Quick Ratio (TTM)	1.25x	4.72x
Debt/Equity (TTM)	0.00x	5.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	0.46
52W Performance	-30.2%	-16.3%
YTD Performance	76.5%	-33.4%
% from 52W High	-63.4%	-48.9%
% from 52W Low	97.1%	84.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.88x
FCF Yield (TTM)	-40.3%	-9.3%
Earnings Yield (TTM)	-38.9%	-23.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-629.5	-26.4
EV/GP/RG	0.00	0.11
Ticker research	View PYXS research	View TLSI research